SS
Suresh Sagarmal Parmar
About Suresh Sagarmal Parmar
Data last updated:
Suresh Sagarmal Parmar has 4 years in corporate governance. Holds Director role. Currently with 2 companies, including Dana Overseas Private Limited and Dana Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹1.96 Cr; the largest is Dana Pharmaceuticals Private Limited at ₹1.96 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 02 Aug 2022 | 1996 | ₹1.96 Cr (FY 2025) | Active | |
| Director | 02 Aug 2022 | 1996 | ₹13,020 (FY 2022) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Suresh Sagarmal Parmar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Suresh Sagarmal Parmar
Suresh Sagarmal Parmar has 4 years in corporate governance. Holds Director role. Currently with 2 companies, including Dana Overseas Private Limited and Dana Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹1.96 Cr; the largest is Dana Pharmaceuticals Private Limited at ₹1.96 Cr (FY 2025).
Suresh Sagarmal Parmar is associated with 2 companies as Director, including Dana Pharmaceuticals Private Limited (₹1.96 Cr), Dana Overseas Private Limited (₹13,020).
Suresh Sagarmal Parmar has expertise in General Business.
Suresh Sagarmal Parmar has 4 years in corporate governance.
By reported revenue, the largest current company of Suresh Sagarmal Parmar is Dana Pharmaceuticals Private Limited, with revenue of ₹1.96 Cr (FY 2025).
The 2 current companies of Suresh Sagarmal Parmar that report revenue have a combined latest revenue of ₹1.96 Cr.
Suresh Sagarmal Parmar currently holds positions at 2 companies: Dana Pharmaceuticals Private Limited (₹1.96 Cr), Dana Overseas Private Limited (₹13,020).